New research published in the journal Drugs and Therapeutics Bulletin suggests that a new testosterone patch designed to treat sexual dysfunction in women may be ineffective, and questions remain about its long-term safety as well. intrinsa was recently approved in Great Britain for women who have gone through menopause because of removal of their ovaries or uterus. But a new study has found that trial data on the drug may be flawed, and researchers say the studies were not long enough to show...